•
Mar 31, 2021

Cocrystal Pharma Q1 2021 Earnings Report

EPS
-$0.48
Previous year: -$0.05
+860.0%
R&D Expenses
$1.6M
G&A Expenses
$1.2M
Cash and Equivalents
$33.3M
Free Cash Flow
-$1.8M
Previous year: -$2.28M
-21.3%
Total Assets
$53.9M
Previous year: $42.8M
+25.7%

Cocrystal Pharma

Cocrystal Pharma